The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade

Neuropsychopharmacology

Volumn 26, Issue 1, 2002, Pages 106-114

  Wand, Gary S ^a   McCaul, Mary ^a   Yang, Xioaju ^a   Reynolds, Joanna ^a   Gotjen, Deidre ^a   Lee, Shing ^a   Ali, Ahmed ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenocorticotropin; Cortisol; Naloxone; Neuroendocrine; Opioid receptor; Polymorphism

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; MU OPIATE RECEPTOR; NALOXONE; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; BINDING AFFINITY; BRAIN FUNCTION; BRAIN NERVE CELL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; EXON; GENETIC POLYMORPHISM; GENOTYPE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MUTATION; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR BLOCKING;

ADULT; AMINO ACID SUBSTITUTION; CARRIER PROTEINS; DNA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MUTATION; NALOXONE; NARCOTIC ANTAGONISTS; NERVE TISSUE PROTEINS; PERSONALITY; POLYMORPHISM, GENETIC; PROTEIN DENATURATION; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0036149110     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00294-9     Document Type: Article

References (44)

1. Effects of third intracerebroventricular injections of corticotropin-releasing factor (CRF) on ethanol drinking and food intake
2. Mu-opioid receptor gene variants: Lack of association with alcohol dependence
3. Neuroendocrine abnormalities in visceral obesity
4. The metabolic syndrome-a neuroendocrine disorder?
5. Naloxone-induced activation of the hypothalamic-pituitary-adrenal axis in suspected central adrenal insufficiency
6. Single-nucleotide polymorphism in the human mu-opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction
7. Variations in maternal care in infancy regulate the development of stress reactivity
8. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: Neuro-endocrine and target tissue-related causes
9. Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: Effects of 5-HT on adrenocortical cells
10. The five-factor model of personality and sexual functioning in outpatient men and women
11. Stability and change in personality assessment: The revised NEO Personality Inventory in the year 2000
12. Personality and polymorphisms of genes involved in aminergic neurotransmission
13. Maternal care, gene expression, and the development of individual differences in stress reactivity
14. Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder
15. The human serotonin transporter gene polymorphism-basic research and clinical implications
16. Effect of corticotropin releasing factor receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in vivo
17. Naltrexone biotransformation and incidence of subjective side effects: A preliminary study
18. Corticotropin-releasing factor, norepinephrine, and stress
19. Drug dependence: Stress and dysregulation of brain reward pathways
20. Detection of single nucleotide polymorphisms of the human mu-opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: Potential in studies of addiction
21. Opioid receptor and peptide gene polymorphisms: Potential implications for addictions
22. The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: Alternative biallelic variation in rhesus monkeys. Rapid communication
23. Genetically driven variation in serotonin uptake: Is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?
24. Evidence for an interaction between alpha-MSH and opioids in the regulation of gonadotropin secretion in man
25. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels
26. Plasma adrenocorticotropin responses to opioid blockade with Naloxone: Generating a dose-response curve in a single session
27. Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects
28. The human mu-opioid receptor: Modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C
29. Glucocorticoids and stress: Permissive and suppressive actions
30. DRD2 gene and alcoholism
31. D2 and D4 dopamine receptor polymorphisms and personality
32. Opioid antagonists in the treatment of alcohol dependence: Clinical efficacy and prevention of relapse
33. Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes
34. Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons
35. Human mu-opioid receptor variation and alcohol dependence
36. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder
37. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders
38. Stress hormones: Good and bad
39. The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death
40. Nalmefene causes greater HPA axis activation than Naloxone in normal volunteers: Implications for the treatment of alcoholism
41. Polymorphism of the gene encoding the alpha subunit of the stimulatory G-protein of adenylyl cyclase (GNAS1)
42. Family history of alcoholism and hypothalamic opioidergic activity
43. The human mu-opioid receptor gene: 5′ regulatory and intronic sequences
44. Genetic factors, perceived chronic stress, and the free cortisol response to awakening